BCL2 and B-cell chronic lymphocytic leukemia: One of the early studies to show the chemo-sensitizing effects targeting Bcl-2 involved treating patients with Bcl-2 antisense (oblimersen sodium) in combination with chemotherapeutic drugs in chronic lymphocytic leukemia, leading to improved survival47, 48.